Exciting developments in universal flu vaccine research are underway, with two promising candidates currently in clinical trials. One vaccine utilizes chimeric h antigens to enhance immune response, while another, a whole virus vaccine, has shown robust protection in mice against various strains. Although further trials are needed to confirm their effectiveness in humans, the prospects are hopeful, especially after the challenges posed by the COVID pandemic.
